GlassScriptPhysician profile
Natasha K Gooden
NPI 1588856421
$2,762.44
in general payments reported to CMS, 2019-2025
34 companies · $515 in 2025
The $515 reported for 2025 was more than what 81% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $47.25 · 2021: $120 · 2022: $644 · 2023: $452 · 2024: $668 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,563 · Education: $71.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,563.38 |
| Education | $71.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $351.16 | 2019-2023 | |
| Coopersurgical, INC. | $301.90 | 2019-2025 | Endosee, Mara Console, Paragard T 380a |
| Hologic Sales and Service, LLC | $197.51 | 2024-2025 | Acessa Provu System, Novasure, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $183.17 | 2023-2025 | Myfembree |
| Pfizer INC. | $166.68 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $148.80 | 2023-2025 | |
| Millicent US INC | $136.65 | 2024-2025 | Intrarosa |
| Myovant Sciences INC. | $130.16 | 2021-2022 | |
| Exeltis, USA INC. | $111.66 | 2019-2025 | Slynd |
| Merck Sharp & Dohme LLC | $107.87 | 2019-2023 | Gardasil 9 |
| Shield Therapeutics INC | $98.74 | 2023-2025 | Accrufer |
| Organon LLC | $95.01 | 2022-2025 | Jada System, Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $90.75 | 2021-2024 | |
| Astellas Pharma US INC | $88.89 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $84.92 | 2022-2025 | Zurzuvae |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $68.33 | 2019 | |
| Agile Therapeutics, INC. | $58.59 | 2022-2024 | Twirla |
| Solventum Corporation | $41.60 | 2025 | Prevena |
| Channel Medsystems, INC. | $38.13 | 2022 | |
| Therapeuticsmd, INC. | $28.52 | 2019-2022 | |
| Covidien LP | $26.93 | 2019 | |
| Optumhealth Care Solutions, LLC | $24.53 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Avion Pharmaceuticals | $24.23 | 2019-2022 | |
| Gynesonics, INC. | $16.55 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mylan Pharmaceuticals INC. | $16.49 | 2022 | |
| American Regent | $16.19 | 2025 | Injectafer |
| Amag Pharmaceuticals, INC. | $15.98 | 2019 | |
| Ascend Therapeutics US, LLC | $15.93 | 2023 | |
| Smith+Nephew, INC. | $14.93 | 2024 | Pico 14 |
| Ethicon US, LLC | $13.93 | 2020 | |
| Mimedx Group, INC. | $13.90 | 2025 | |
| Minerva Surgical, INC | $13.77 | 2022 | |
| Glaxosmithkline, LLC. | $11.62 | 2019 | |
| Meditrina | $8.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Gooden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.